Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Behavioural Brain Research|March 27, 2016
Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in micePaula Mosińska, Katarzyna Socała, Dorota Nieoczym, et al.
The American Journal of Gastroenterology|March 29, 2017
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting SyndromeAndrzej Wasilewski, Urszula Lewandowska, Paula Mosinska, et al.
Gastroenterology|November 15, 2006
Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colonRudolf Schicho, Dagmar Krueger, Florian Zeller, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 2020
Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tractAgata Szymaszkiewicz, Jakub Włodarczyk, Andrzej Wasilewski, et al.
Frontiers in Immunology|January 26, 2023
Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cellsArailym Sarsembayeva, Melanie Kienzl, Eva Gruden, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2017
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factorsNicole Golob-Schwarzl, Stefanie Krassnig, Anna M Toeglhofer, et al.
Phytotherapy Research : PTR|January 3, 2007
The Chinese herbal preparation Qing Yi Tang (QYT) improves intestinal myoelectrical activity and increases intestinal transit during acute pancreatitis in rodentsYong-Yu Li, Andrei Sibaev, Ming-Zheng Zhou, et al.
Deutsche Medizinische Wochenschrift (1946)|August 12, 2015
[Fecal microbiota transfer (FMT) in a patient with refractory irritable bowel syndrome]Verena Zoller, Anna-Lena Laguna, Olivia Prazeres Da Costa, et al.
Scientific Reports|February 22, 2019
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancerMagdalena Grill, Christoph Högenauer, Andreas Blesl, et al.
Nature Reviews. Gastroenterology & Hepatology|September 28, 2022
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndromeStuart M Brierley, Beverley Greenwood-Van Meerveld, Giovanni Sarnelli, et al.
Pageof 17